Tricyclic drugs for depression in children and adolescents
Cochrane Database of Systematic ReviewsPublished 22 April 2002
Philip Hazell, Dianne O'Connell, Diane Heathcote, David Henry
Citations171
SJR quartileQ1
SJR score1.62
SNIP2.04
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Data suggest tricyclic antidepressants are not useful in treating depression in pre pubertal children, and there is marginal evidence to support the use of tricyClic antidepressants in the treatment of depression in adolescents.
Abstract
Data suggest tricyclic antidepressants are not useful in treating depression in pre pubertal children. There is marginal evidence to support the use of tricyclic antidepressants in the treatment of depression in adolescents, although the magnitude of effect is likely to be moderate at best.
Keywords
PsychologyMedicine
Journal of the American Academy of Child & Adolescent PsychiatryChildhood and Adolescent Depression: A Review of the Past 10 Years. Part I
2,091 Citations1996Boris Birmaher, Neal D. Ryan +6 more
Archives of General PsychiatryA Double-blind, Randomized, Placebo-Controlled Trial of Fluoxetine in Children and Adolescents With Depression
998 Citations1997Graham J. Emslie
Fluoxetine was superior to placebo in the acute phase treatment of major depressive disorder in child and adolescent outpatients with severe, persistent depression, and complete remission of symptoms was rare.
Journal of the American Academy of Child & Adolescent PsychiatryEfficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled Trial
648 Citations2001Martin B. Keller, Neal D. Ryan +20 more
Paroxetine demonstrated significantly greater improvement compared with placebo in Hamilton Rating Scale for Depression total score < or = 8, HAM-D depressed mood item, K-SADS-L depressed Mood item, and CGI score of 1 or 2.
BMJEfficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis
312 Citations1995Philip Hazell, Dianne O’Connell +3 more
An overall small but clinically non-significant treatment effect is found and tricyclic drugs are not recommended as a first line treatment for depression in children and adolescents.
Archives of General PsychiatryImipramine in Prepubertal Major Depressive Disorders
279 Citations1987Joaquim Puig-Antich
The results suggest that the mean imipramine dosage was too low, and that future double-blind, placebo-controlled studies of imipramsine in prepubertal major depression should include plasma level titration to above 150 ng/mL and an initial placebo washout period.
The British Journal of PsychiatrySchool Phobia: A Therapeutic Trial with Clomipramine and Short-Term Outcome
197 Citations1981Thomas P. Berney, I. Kolvin +5 more
It was found that there was a rapid relief of depression but neurotic symptomatology tended to persist, and neither age nor sex were significantly related to improvement, except on one behavioural measure where girls initially did better than boys.
Journal of the American Academy of Child & Adolescent PsychiatryComparative Studies of Pharmacotherapy for School Refusal
185 Citations1990Gail A. Bernstein, Barry D. Garfinkel +1 more
Additional research is needed to determine whether trends in this study are explained by drug effect or baseline differences on rating scales, as well as analyses of covariance, which showed no significant differences among the three treatment groups on change in anxiety and depression scales.
Journal of the American Academy of Child & Adolescent PsychiatryAnother Sudden Death in a Child Treated with Desipramine
182 Citations1993Mark A. Riddle, Barbara Geller +1 more
New information is provided about three children receiving the tricyclic antidepressant medication desipramine for behavioral disorders and a fourth case is described, suggesting the cardiac long QT syndrome may be a mechanism for these sudden deaths.
Journal of the American Academy of Child & Adolescent PsychiatryPsychopharmacology in Child and Adolescent Psychiatry: A Review of the Past Five Years
181 Citations1988Magda Campbell, ELIZABETH KAY SPENCER
Journal of the American Academy of Child & Adolescent PsychiatrySudden Death in Children Receiving Norpramin®: A Review of Three Reported Cases and Commentary
180 Citations1991Mark A. Riddle, J. Craig Nelson +5 more
The purpose of this commentary is to review what is known about the three reported cases of sudden death in children and to discuss the implications of these tragedies for children receiving treatment with tricyclic drugs.
Journal of the American Academy of Child & Adolescent PsychiatrySudden Death in Children Treated with a Tricyclic Antidepressant
148 Citations1991J Biederman
PubMedDouble-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design.
142 Citations1989B Geller, T B Cooper +3 more
Journal of the American Academy of Child & Adolescent PsychiatryPharmacokinetically Designed Double-blind Placebo-controlled Study of Nortriptyline in 6− to 12-Year-Olds with Major Depressive Disorder
131 Citations1992Barbara Geller, Thomas B. Cooper +4 more
There was a poor rate of response in both treatment groups, and active subjects did not evidence the anticholinergic side effects reported in adult samples.
Journal of the American Academy of Child PsychiatryClinical Effects of Amitriptyline in Adolescent Depression: A Pilot Study
129 Citations1981Alan D. Kramer, Robert J. Feiguine
The results suggest that prescription of amitriptyline for treatment of adolescent depression may be no more efficacious than the use of placebo.
Journal of the American Academy of Child & Adolescent PsychiatryResponse to Desipramine Treatment in Adolescent Depression: A Fixed-Dose, Placebo-Controlled Trial
117 Citations1994Stan Kutcher, Carolyn Boulos +9 more
The routine use of short-term tricyclic antidepressant DMI in the treatment of adolescent depression is not supported by the data on hand and further investigations into what constitutes optimal psychopharmacological treatment of adolescents are warranted.
Journal of the American Academy of Child & Adolescent PsychiatryRandomized, Controlled Trial of Amitriptyline Versus Placebo for Adolescents With “Treatment-Resistant” Major Depression
115 Citations1998Boris Birmaher, G. Scott Waterman +11 more
Although both treatment groups showed substantial response, at the end of treatment a substantial proportion of patients still had MDD of subsyndromal symptoms of depression, and this and other studies of tricyclic antidepressants question the use of this medication as first-line treatment for youths with MDD.
American Journal of PsychiatryPulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial
92 Citations1997F.R. Sallee, N. Vrindavanam +3 more
Pulse clomipramine (200 mg i.v.) is associated with dramatic reduction in depressive symptoms at day 6 after infusion, which is significantly different from the effect of placebo.
PubMedThe effect of concomitant disorders in childhood depression on predicting treatment response.
88 Citations1990C W Hughes, S H Preskorn +4 more
Findings could explain why studies of prepubertal-onset depression found no differences between drug and placebo treatment assuming that a large percentage of the studies' subjects had concomitant conduct or oppositional disorders.
Journal of the American Academy of Child & Adolescent PsychiatryEffect of Tricyclic Antidepressants on Switching to Mania and on the Onset of Bipolarity in Depressed 6− to 12-Year-Olds
84 Citations1993Barbara Geller, Louis Fox +1 more
The authors present data on the rates of onset of bipolar phenomena, at 2- to 3-year follow-up, in depressed 6- to 12-year olds and discuss the implications for the prescription of TCAs to children who present with major depressive disorder and have a family history ofipolarity or a history of bipolar symptoms.
Journal of the American Academy of Child & Adolescent PsychiatryA Randomized, Controlled Trial of Amitriptyline in the Acute Treatment of Adolescent Major Depression
84 Citations1996CHRISTOPHER H. KYE, G. Scott Waterman +5 more
No definitive recommendation can be made regarding the efficacy of tricyclic antidepressants in the treatment of adolescent MDD.
PubMedDepression in children: relationship between plasma imipramine levels and response.
82 Citations1982Preskorn Sh, Weller Eb +1 more
Responsibility to the drug was concentration-dependent; of the children who achieved total tricyclic plasma levels of 125-225 ng/ml, 92% responded, compared with 25% of those outside this range, and Antidepressant response was correlated both with total tricycle plasma levels and with plasma desipramine levels.
Journal of the American Academy of Child PsychiatryAmitriptyline in Children with Major Depressive Disorder: A Double-Blind Crossover Pilot Study
76 Citations1984Javad H. Kashani, Walid O. Shekim +1 more
Results indicate that amitriptyline may have a place in the treatment of childhood depression.
Journal of Child and Adolescent PsychopharmacologyPsychopharmacology of Child and Adolescent Major Depression: Present Status and Future Directions
50 Citations1992Peter S. Jensen, Neal D. Ryan +1 more
The next generation of treatment research in child and adolescent depression may require innovative, multisite, longitudinal treatment designs which allow the simultaneous possibility for the continuing clarification and validation of depressive syndromes and treatment-responsive subgroups.
Depression and AnxietyAdolescent depression: Controlled desipramine treatment and atypical features
46 Citations1998Rachel G. Klein, Salvatore Mannuzza +5 more
A relatively high rate of atypical depression was observed, suggesting the need for very large samples to detect differential treatment efficacy, should it exist in adolescents with major depression, and may have relevance to future investigation of therapeutic interventions in adolescent MDD.
Psychiatric Clinics of North AmericaThe Pharmacologic Treatment of Child and Adolescent Depression
43 Citations1992Neal D. Ryan
The evidence of continuity of child and adolescent depression into adult depression, of familial transmission of this disorder from parent to child, and the similar syndromic picture all strongly argue that, by extrapolation, pharmacologic agents with proven efficacy in adult depression are likely candidates for the pharmacologic treatment of children and adolescents with this disorder.
PubMedResponse to desipramine treatment in adolescent major depression.
41 Citations1991Carolyn Boulos, Stan Kutcher +4 more
Thirty adolescents who met DSM-III-R criteria for major depressive disorder completed a double-blind, placebo-controlled, 6-week, fixed-dose (200 mg daily) study of desipramine (DMI).
Acta Psychiatrica ScandinavicaMeta‐analysis of early phase I1 studies with paroxetine in hospitalized depressed patients
20 Citations1989Majella Byrne